These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5023726)

  • 1. [Our experience in the treatment of peripheral vascular diseases with raubasine].
    Vercellio G; Costantini S; Giulini S
    Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
    Florio F; Ruffolo S; Piro E
    Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
    Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
    Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Raubasine in arterial pathology of the extremities].
    Perrin M
    Lyon Med; 1965 May; 213(21):1585-90. PubMed ID: 5828799
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical action in vascular pathology of the limbs, of an original association of raubasine and 711 SE].
    Bouret G; Coget JM; Merlen JF; Warembourg H
    Lille Med; 1970 Mar; 15(3 Suppl 2):440-3. PubMed ID: 5421804
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the association of raubasine and dihydroergocristine in the aged patient with vascular disease].
    Sauter R
    Lille Med; 1971; 17():Suppl 3:551-8. PubMed ID: 5005074
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of drugs acting on the smooth musculature by direct and indirect routes in therapy of vascular diseases].
    Labò G; Pretolani E
    Cardiol Prat; 1971 Feb; 22(1):1-9. PubMed ID: 4398064
    [No Abstract]   [Full Text] [Related]  

  • 8. [The association of raubasine and ergot derivatives in therapy of peripheral vascular diseases].
    Sforza M; Perelli-Ercolini M
    Minerva Cardioangiol; 1967 Oct; 15(10):655-8. PubMed ID: 5611109
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of peripheral vascular disorders with dilatol].
    Knapik Z; Twardzicki J; Wlodarczykowa J
    Pol Tyg Lek; 1965 Jun; 20(23):846-8. PubMed ID: 5841123
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new peripheral vasodilator agent. Personal experience with naphtidrofuryl].
    Romero RL; Vives C; Pastor C; Valdivia Velarde H; Basso G; Bordone JC
    Prensa Med Argent; 1970 May; 57(11):537-42. PubMed ID: 5454084
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with the vasodilator agent spasmocyclone].
    Priessnitz O
    Med Welt; 1966 Jun; 26():1433-6. PubMed ID: 5962718
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of Cinnarizine in patients with peripheral vascular diseases].
    Simões Neto E
    Hospital (Rio J); 1971 Jan; 79(1):189-98. PubMed ID: 5316651
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
    Giulini SM; Agus GB; De Cristoforo A
    Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
    [No Abstract]   [Full Text] [Related]  

  • 15. [Action of MD 1035 in peripheral vascular manifestations].
    Barraine R; Efthymiou TP; Marcantoni JP
    Presse Med (1893); 1970 Dec; 78(53):2389-90. PubMed ID: 5489156
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic effects of slow acting nicotinyl alcohol in vascular diseases].
    Chiti E
    Clin Ter; 1965 Oct; 35(1):38-53. PubMed ID: 5860388
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the therapy of peripheral circulatory disorders with the new angioactivator Tebonin of plant origin].
    Krammer F
    Med Welt; 1966 Jul; 28():1524-8. PubMed ID: 5984513
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of a compound of Euclidan and synthetic local anesthetics, by endarterial injection, in the treatment of 45 cases of vascular disease. Clinical results].
    Reboul H; Vergoz L
    Clinique (Paris); 1965 Jun; 60(608):449-60. PubMed ID: 5845021
    [No Abstract]   [Full Text] [Related]  

  • 19. [Flunarizine in patients with inadequate cerebral and peripheral circulation. Multicentric double blind study].
    Domschky K; Nelson M; Dammhayn B; Terjung E
    Med Welt; 1977 Jun; 28(23):1062-4. PubMed ID: 886963
    [No Abstract]   [Full Text] [Related]  

  • 20. [Veno-Tebonin a new active principle for treatment of venous diseases].
    Fladung P; Gerbig H; Kladetzky A; Oswald F; Wirtler A
    Ther Ggw; 1969 Sep; 108(9):1309-10 passim. PubMed ID: 5382172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.